Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease
By Elana Gotkine HealthDay Reporter
MONDAY, June 30, 2025 -- For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the triglyceride-glucose (TyG) index experience faster cognitive decline, according to a study presented at the 11th Congress of the European Academy of Neurology, held from June 21 to 24 in Helsinki.
Bianca Gumina, M.D., from the University of Brescia in Italy, and colleagues conducted a retrospective study to examine insulin resistance (using TyG as a surrogate marker for insulin resistance) as a progression marker in patients with a cerebral spinal fluid-based diagnosis of AD or other neurodegenerative diseases (NDDs) who were nondiabetic. Patients were stratified into tertiles according to TyG index (low, medium, high). A total of 315 patients entered the study: 210 with AD and 115 with other NDDs.
The researchers found that high TyG index was linked to worse blood-brain-barrier markers in AD and interacted with APOE ε4, with no effect seen in other NDDs. More cardiovascular risk factors were exhibited in patients with AD with high TyG index, while baseline characteristics were similar. In the MCI-AD subgroup (161 patients), high TyG index was significantly associated with faster cognitive decline over three years of follow-up (hazard ratio, 4.08). For MCI-to-dementia conversion, there was a similar but nonsignificant trend observed. For progression, there was no significant TyG index-APOE interaction. In the other NDDs group, TyG index showed no impact on clinical progression.
"We were surprised to see the effect only in the Alzheimer's spectrum and not in other neurodegenerative diseases," Gumina said in a statement. "It suggests a disease-specific vulnerability to metabolic stress during the prodromal window, when interventions may still change the trajectory."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Metformin Use Tied to Lower Risk for Dementia, Death in Adults With Overweight, Obesity
TUESDAY, Aug. 12, 2025 -- Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or...
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
WEDNESDAY, Aug. 6, 2025 -- Cognitive functional therapy (CFT), with or without biofeedback, is more effective than usual care for treating patients with chronic disabling low back...
Avoidable All-Cause Hospitalization, ED Visits Common in Nursing Homes
MONDAY, Aug. 4, 2025 -- Among severely impaired and terminally ill nursing home (NH) residents, all-cause hospitalizations (ACH) and emergency department visits without...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.